| Product Code: ETC10075834 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Hereditary Angioedema Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Hereditary Angioedema Market - Industry Life Cycle |
3.4 Vietnam Hereditary Angioedema Market - Porter's Five Forces |
3.5 Vietnam Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Vietnam Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Vietnam Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about hereditary angioedema among healthcare professionals and patients |
4.2.2 Rising prevalence of hereditary angioedema cases in Vietnam |
4.2.3 Growing investment in healthcare infrastructure and facilities in the country |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment and therapies for hereditary angioedema in certain regions of Vietnam |
4.3.2 High costs associated with long-term management and treatment of hereditary angioedema |
4.3.3 Lack of comprehensive insurance coverage for hereditary angioedema treatments |
5 Vietnam Hereditary Angioedema Market Trends |
6 Vietnam Hereditary Angioedema Market, By Types |
6.1 Vietnam Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Vietnam Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 Vietnam Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 Vietnam Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 Vietnam Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 Vietnam Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 Vietnam Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Vietnam Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Vietnam Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Vietnam Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 Vietnam Hereditary Angioedema Market Export to Major Countries |
7.2 Vietnam Hereditary Angioedema Market Imports from Major Countries |
8 Vietnam Hereditary Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in diagnosing and treating hereditary angioedema |
8.2 Percentage increase in diagnosed cases of hereditary angioedema annually |
8.3 Accessibility and availability of specialized treatment centers for hereditary angioedema patients |
9 Vietnam Hereditary Angioedema Market - Opportunity Assessment |
9.1 Vietnam Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Vietnam Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Vietnam Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Hereditary Angioedema Market - Competitive Landscape |
10.1 Vietnam Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here